[1]Cleeman JI.Executive summary of the third repot of the national cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel Ⅲ)[J]. J A M A, 2001,285:2486. [2]血脂异常防治对策专题组.血脂异常防治建议[J].中华心血管杂志，1997,25:169. [3]Chong PH,Seeger JD,Franklin C.Clinically relevent differences between the statins:implications for therapeutic selection[J]. Am J Med, 2001,111:390. [4]Maron DJ，Fazio S，Linton MF.Current perspectives on statins[J]. Circulation, 2000,101:207. [5]Plenge JK，Hernandez TL，Weil KM, et al. Simvastatin lowers creactive protein within 14 days An effect independent of low density lipoprotein cholestero reduction[J]. Circulation, 2002,106:1447. [6]Scandinavian Simvastatin Survival Study Group.Randomised trial of cholestrol lowering in 4 444 patients with coronary heart disease:the scandiwavian simvastatin survival stuay (4s)[J]. Lancet, 1994,344:1383. [7]Heart Protection Study Collborative Group.MRC/BHF Heart protection study of cholesterol lowering with simvastatin in 20536 high risk individuals;a randomised placebo controlled trial[J]. Lancet, 2002,306:7. [8]陈红.辛伐他汀达标研究[J].中国医药导刊,2001,4:285. [9]Pedersen TR，Berg K，Cook TJ, et al. Safety and tolerability of cholesterol lowering with simvastatin during 5 year in the scandinavian simvastatin survival study[J]. Arch Intern Med, 1996,156;2085. [10]Pedersen TR，Wilhelmsen L，Faergeman O, et al. Follow up study of patientis randomized in the scandinavian simvastatin survival study (4 s) of cholesterol lowering[J]. Am J Cardiol, 2000,86:257. [11]Waldman A，Kritharids L.The pleiotropic effects of HMG CoA reductase inhibitors[J]. Drugs, 2003,63:139.